238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-3.63%
Both yoy net incomes decline, with META at -176.59%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
31.12%
D&A growth well above META's 26.36%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-146.05%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
18.35%
Less SBC growth vs. META's 973.79%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
196.93%
Slight usage while META is negative at -2368.18%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-173.75%
Both yoy AR lines negative, with META at -263.08%. Martin Whitman would suspect an overall sector lean approach or softer demand.
117.21%
Some inventory rise while META is negative at -1684.21%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-247.34%
Both negative yoy AP, with META at -66.67%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
322.95%
Some yoy usage while META is negative at -870.00%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-111.46%
Both negative yoy, with META at -511.32%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
15.11%
Some CFO growth while META is negative at -45.12%. John Neff would note a short-term liquidity lead over the competitor.
-27.51%
Negative yoy CapEx while META is 8.83%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-10610.87%
Both yoy lines negative, with META at -2100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
20.91%
Some yoy expansion while META is negative at -593.61%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-68.21%
Both yoy lines are negative, with META at -5.97%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-237.14%
Both yoy lines negative, with META at -100.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-251.96%
Both yoy lines negative, with META at -795.83%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-102.79%
Both yoy lines negative, with META at -1.41%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
-191.49%
We cut yoy buybacks while META is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.